Select from the search options to widen or narrow the search results.
This research study will look at whether there is an advantage to scheduled dosing of rituximab over the standard retreatement given as needed when a relapse occurs.
Participants must:
Must have biopsy proven diagnosis of non-Hodgkin's lymphoma
Must be at least 18 years old
For more information Please contact Pam Rynes,RN 649-6067
Clinical trial location(s)
AMG Aurora Health Center - Slinger 1061 East Commerce Blvd Slinger, WI 53086
Aurora Sinai Medical Center 945 North 12th Street Milwaukee, WI 53233